Cvs Pharmacy # is an authorized DME supplier for medicare equipments and products.
Cvs Pharmacy # is a Community/Retail Pharmacy in Burleson, Texas. This pharmacy is owned and operated by Cvs Pharmacy Inc.. It is located at 200 Nw John Jones Dr, Burleson and it's customer support contact number is 817-302-0059. The authorized person of Cvs Pharmacy # is Susan Colbert who is Sr. Director, Payer Relations of the pharmacy and his contact number is 401-770-2751. Active license number of Cvs Pharmacy # is 30488 for Community/Retail Pharmacy in Texas. Cvs Pharmacy # accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Cvs Pharmacy # is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Cvs Pharmacy # type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Cvs Pharmacy #
Type:
Community/Retail Pharmacy
Location:
200 Nw John Jones Dr, Burleson, Texas, 76028-5615
Phone:
817-302-0059
Fax:
682-233-9769
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Susan Colbert
Position:
Sr. Director, Payer Relations
Contact Number:
401-770-2751
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1679595342
NPI Enumeration Date:
24 Jul, 2006
NPI Last Update On:
25 Aug, 2016
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Cvs Pharmacy # are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
30488
Texas
Primary
Durable Medical Equipment & Medical Supplies
Secondary
Pharmacy
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
2097659
Other
Pk
Medicare Enrollment:
Cvs Pharmacy # is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
5092711895
O20161209000460
Cvs Pharmacy Inc
DME SUPPLIER - PHARMACY
Products Available:
Cvs Pharmacy # has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Mail Order
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Enteral Equipment And/or Supplies
Enteral Nutrients
Heat & Cold Applications
Nebulizer Equipment & Supplies
Ostomy Supplies
Parenteral Equipment And/or Supplies
Parenteral Nutrients
Surgical Dressings
Urological Supplies
Walkers
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1 Cvs Dr, Box 1075 Woonsocket, Rhode Island
Zip:
02895-6146
Phone Number:
401-765-1500
Fax Number:
--
Patients can reach Cvs Pharmacy # at 200 Nw John Jones Dr, Burleson, Texas or can call on customer care at 817-302-0059.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.